HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• The (non)smoking gun: Experts identify alarming increase in lung cancer among never-smokers
• How do transplants cure leukemia? Robert Peter Gale, MD, PhD; Mine Harada, MD, PhD
• Optimal management of esophageal, gastroesophageal junction cancers remains controversial David H. Ilson, MD, PhD
• Studies highlight exciting trends in prognostic markers, combinations for myelofibrosis Aaron T. Gerds, MD, MS
• Myeloproliferative Neoplasms and Myelodysplastic Syndrome Drugs in the Pipeline
• Disparities of cancer care in the US will not go away ... unless we do something about it in an election year Derek Raghavan, MD, PhD, FACP, FRACP, FASCO
• FDA approves EMEND to prevent nausea, vomiting after moderately emetogenic chemotherapy
• FDA grants breakthrough therapy designation to durvalumab for bladder cancer
• FDA grants breakthrough therapy designation to IMMU-132 for triple-negative breast cancer
• FDA grants breakthrough therapy designation to midostaurin for newly diagnosed AML
• FDA grants orphan drug designation to tazemetostat for treatment of malignant rhabdoid tumors
• FDA places full clinical hold on pacritinib
• ACA coverage expansion linked to earlier cervical cancer diagnosis among younger women
• Addition of lenalidomide to standard therapy fails to prolong PFS in multiple myeloma
• Breast cancer survivors gain significantly more weight than cancer-free women
• Citrus consumption may increase malignant melanoma risk
• Comprehensive screening fails to increase occult cancer detection after unprovoked VTE
• Continuous therapy improves PFS, OS in newly diagnosed multiple myeloma
• Costs, adverse event rates higher among black men who undergo radical prostatectomy
• Early initiation of chemotherapy may prolong DFS for early breast cancer
• Efficacy of urinary biomarkers varies for bladder cancer detection
• Estrogen, progestin combination decreases endometrial cancer risk in postmenopausal women
• Extent of lymphadenectomy may not influence survival in esophageal cancer
• Family history fails to predict germline mutations in pediatric cancers
• Hypofractionated radiation reduces toxic effects for women with early-stage breast cancer
• Light consumption of alcohol may reduce MDS risk
• MYC rearrangement may influence OS, treatment efficacy for DLBCL
• Older age, asparaginase treatment associated with thromboembolism in pediatric ALL
• Panel issues framework for allocation of scarce pediatric oncology drugs
• Pediatric Hodgkin’s lymphoma outcomes appear worse among black patients
• Researchers quantify risk for cardiovascular disease after Hodgkin's lymphoma treatment
• USPSTF recommends aspirin to prevent colorectal cancer, CVD
• Young black women have higher frequency of BRCA mutations than previously thought
• Younger patients with NSCLC more likely to harbor targetable mutations, experience poor OS
• Bladder cancer institute at Johns Hopkins named director
• Blood cancer expert joins Waxman Foundation advisory board
• Lung cancer expert named to NCI board
• Oncologist joins Roswell Park Cancer Institute, University at Buffalo
• Vanderbilt names registry medical director
• Winship Cancer Institute appoints deputy director
• Chemoradiotherapy improves survival in some elderly patients with head, neck cancer
• High-dose cyclophosphamide may reduce severe GVHD after HSCT
• Imaging, exams detect majority of HPV-positive oropharyngeal cancer recurrences
• Medicaid, uninsured patients experience worse head and neck cancer outcomes
• Plerixafor, G-CSF may serve as preferred stem cell mobilization for multiple myeloma
• Self-reported depression, anxiety lead to poorer outcomes for patients with chronic GVHD
• Smoking status linked to distinct mutation patterns in HPV-positive oropharyngeal cancer
• Triage system reduces ED use for cancer pain management
• Women with early-stage breast cancer frequently undergo potentially unnecessary imaging